Elena G. Mendelevich

Elena G. Mendelevich

Auto-generated profile, based on publicly available information

Elena G. Mendelevich

Kazan State Medical University, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2004 in Neurology
Verified
Journal Article
Closed access
PDF file
EBEnver Bogdanov
Enver Bogdanov
JHJohn David Heiss
John David Heiss
EME. G. Mendelevich
E. G. Mendelevich
IMI. M. Mikhaylov
I. M. Mikhaylov
AHA. Haass
A. Haass
In some adult patients with cervical syringomyelia, MRI studies do not identify primary disease within the foramen magnum or spinal canal. To identify the etiology of this idiopathic type of syringomyelia, clinical features and posterior fossa (PF) measurements from 17 of these patients, 17 patients with Chiari I-type syringomyelia, and 32 control subjects were compared. Idiopathic syringomyelia and Chiari I-type syringomyelia manifested central cervical myelopathy and a small PF with narrow CSF spaces, suggesting that they develop by the same mechanism.


21 May 2018 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
EBEnver Bogdanov
Enver Bogdanov
AFAisylu T Faizutdinova
Aisylu T Faizutdinova
EMElena G Mendelevich
Elena G Mendelevich
ASAlexey S Sozinov
Alexey S Sozinov
JHJohn David Heiss
John David Heiss
BACKGROUND: Epidemiology can assess the effect of Chiari I malformation (CM1) on the neurological health of a population and evaluate factors influencing CM1 development. OBJECTIVE: To analyze the regional and ethnic differences in the prevalence of CM1. METHODS: The population of the Republic of Tatarstan (RT) in the Russian Federation was evaluated for patients with CM1 symptoms over an 11-yr period. Typical symptoms of CM1 were found in 868 patients. Data from neurological examination and magnetic resonance imaging (MRI) measurement of posterior cranial fossa structures were analyzed. RESULTS: MRI evidence of CM1, defined as cerebellar tonsils lying at least 5 mm inferior to the foramen magnum, was found in 67% of symptomatic patients. Another 33% of symptomatic patients had 2 to 4 mm of tonsillar ectopia, which we defined as “borderline Chiari malformation type 1 (bCM1).” The period prevalence in the entire RT for symptomatic CM1 was 20:100 000; for bCM1 was 10:100 000; and for CM1 and bCM1 together was 30:100 000. Prevalence of patients with CM1 symptoms was greater in the northern than southern districts of Tatarstan, due to a high prevalence (413:100 000) of CM1 in the Baltasy region in one of the northern districts. CONCLUSION: One-third of patients with typical symptoms of CM1 had less than 5 mm of tonsillar ectopia (bCM1). Assessments of the health impact of CM1-type symptoms on a patient population should include the bCM1 patient group. A regional disease cluster of patients with Chiari malformation was found in Baltasy district of RT and needs further study.

6 March 2006 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
EBEnver Bogdanov
Enver Bogdanov
JHJohn David Heiss
John David Heiss
EME. G. Mendelevich
E. G. Mendelevich

26 September 2000 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
EBEnver Bogdanov
Enver Bogdanov
MIM. M. Ibatullin
M. M. Ibatullin
EME. G. Mendelevich
E. G. Mendelevich

29 August 2017 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
Svetlana KhaiboullinaSvetlana Khaiboullina
Svetlana Khaiboullina
EMElena G. Mendelevich
Elena G. Mendelevich
LSLeyla Shigapova
Leyla Shigapova
ESElena Shagimardanova
Elena Shagimardanova
GGGuzel Gazizova
Guzel Gazizova
Albert A RizvanovAlbert A Rizvanov
Albert A Rizvanov
Background. Immune mechanisms recently emerged as important contributors to migraine pathology with cytokines affecting neuronal excitation. Therefore, elucidating the profile of cytokines activated in various forms of migraine, including those with a known genetic cause, can help in diagnostic and therapeutic approaches. Methods. Here we (i) performed exome sequencing to identify the causal gene mutation and (ii) measured, using Bio-Plex technology, 22 cytokines in serum of patients with familial migraine (two with hemiplegic migraine and two with migraine with aura) from a Russian family that ethnically belongs to the Tatar population. MRI scanning was used to assess cerebellar atrophy associated with migraine in mutation carriers. Results. Whole-exome sequencing revealed the R583Q missense mutation in the CACNA1A gene in the two patients with hemiplegic migraine and cerebellar ataxia with atrophy, confirming a FHM1 disorder. Two further patients did not have the mutation and suffered from migraine with aura. Elevated serum levels of pro-inflammatory and pro-nociceptive IL-6 and IL-18 were found in all four patients (compared to a reference panel), whereas pro-apoptotic SCGF- and TRAIL were higher only in the patients with the FHM1 mutation. Also, cytokines CXCL1, HGF, LIF and MIF were found particularly high in the two mutation carriers, suggesting a possible role of vascular impairment and neuroinflammation in disease pathogenesis. Notably, some ‘algesic’ cytokines, such as β-NGF and TNFβ, remained unchanged or even down-regulated. Conclusion. We present a detailed genetic, neurological and biochemical characterization of a small Russian FHM1 family and revealed evidence for higher levels of specific cytokines in migraine patients that support migraine-associated neuroinflammation in the pathology of migraine.